Quick Answer
INTEGRATED BIOPHARMA INC reported Total Assets of $24.90 million for fiscal year 2025.
INTEGRATED BIOPHARMA INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $24.90M | -5.0% |
| 2024 | $26.21M | +3.1% |
| 2023 | $25.43M | +0.7% |
| 2022 | $25.25M | -0.7% |
| 2021 | $25.44M | +10.9% |
| 2020 | $22.94M | +15.9% |
| 2019 | $19.79M | +35.8% |
| 2018 | $14.57M | -4.1% |
| 2017 | $15.20M | +8.9% |
| 2016 | $13.95M | +20.0% |
| 2015 | $11.62M | +0.3% |
| 2014 | $11.58M | -8.2% |
| 2013 | $12.61M | +6.2% |
| 2012 | $11.88M | -13.0% |
| 2011 | $13.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $23.55M | -8.2% | -7.8% |
| September 30, 2025 | $25.54M | -2.5% | +2.6% |
| June 30, 2025 | $24.90M | -5.0% | -2.9% |
| March 31, 2025 | $25.66M | -4.8% | -0.0% |
| December 31, 2024 | $25.66M | -0.2% | -2.0% |
| September 30, 2024 | $26.18M | -1.7% | -0.1% |
| June 30, 2024 | $26.21M | +0.0% | -2.7% |
| March 31, 2024 | $26.94M | +0.2% | +4.7% |
- INTEGRATED BIOPHARMA INC showed a decrease of -5.0% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, INTEGRATED BIOPHARMA INC’s total assets has grown by 82.4% (from $13.65 million to $24.90 million).
- The most recent figure is from INTEGRATED BIOPHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: